GALECTIN THERAPEUTICS INC. Preferred Stock Dividends, Income Statement Impact
GALECTIN THERAPEUTICS INC. (GALT) reported Preferred Stock Dividends, Income Statement Impact of $97.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2023-03-30
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2021-12-31 was $67.00K, a 3.08% increase year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2021-09-30 was $37.00K, a 208.33% increase year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2020-12-31 was $65.00K, a 0.00% change year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for the quarter ending 2020-09-30 was $12.00K, a 65.71% decline year-over-year.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2022 was $97.00K, a 43.27% decline from fiscal 2021.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2021 was $171.00K, a 24.82% increase from fiscal 2020.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2020 was $137.00K, a 47.91% decline from fiscal 2019.
- GALECTIN THERAPEUTICS INC. preferred stock dividends, income statement impact for fiscal 2019 was $263.00K, a 77.07% decline from fiscal 2018.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month | Preferred Stock Dividends, Income Statement Impact 132 month | Preferred Stock Dividends, Income Statement Impact 135 month | Preferred Stock Dividends, Income Statement Impact 138 month | Preferred Stock Dividends, Income Statement Impact 141 month | Preferred Stock Dividends, Income Statement Impact 144 month | Preferred Stock Dividends, Income Statement Impact 147 month | Preferred Stock Dividends, Income Statement Impact 150 month | Preferred Stock Dividends, Income Statement Impact 153 month | Preferred Stock Dividends, Income Statement Impact 156 month | Preferred Stock Dividends, Income Statement Impact 159 month | Preferred Stock Dividends, Income Statement Impact 162 month | Preferred Stock Dividends, Income Statement Impact 165 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $97.00K 10-K · filed 2023-03-30 | |||||||||||||||
| 2021-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $104.00K derived: sum of 2 quarters · filed 2023-03-30 | $171.00K 10-K · filed 2023-03-30 | |||||||||||||
| 2021-09-30 | $37.00K 10-Q · filed 2021-11-15 | $104.00K 10-Q · filed 2021-11-15 | ||||||||||||||
| 2020-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $77.00K derived: sum of 2 quarters · filed 2022-03-31 | $143.00K derived: sum of 3 quarters · filed 2022-03-31 | $137.00K 10-K · filed 2022-03-31 | ||||||||||||
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-15 | $78.00K derived: sum of 2 quarters · filed 2021-11-15 | $72.00K 10-Q · filed 2021-11-15 | $137.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | $66.00K 10-Q · filed 2020-08-10 | $60.00K 10-Q · filed 2020-08-10 | $125.00K derived: sum of 3 quarters · filed 2021-03-31 | $160.00K derived: sum of 4 quarters · filed 2021-03-31 | ||||||||||||
| 2020-03-31 | -$6.00K 10-Q · filed 2020-05-11 | $59.00K derived: sum of 2 quarters · filed 2021-03-31 | $94.00K derived: sum of 3 quarters · filed 2021-03-31 | $161.00K derived: sum of 4 quarters · filed 2021-03-31 | ||||||||||||
| 2019-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $100.00K derived: sum of 2 quarters · filed 2021-03-31 | $167.00K derived: sum of 3 quarters · filed 2021-03-31 | $263.00K 10-K · filed 2021-03-31 | ||||||||||||
| 2019-09-30 | $35.00K 10-Q · filed 2020-11-09 | $102.00K derived: sum of 2 quarters · filed 2020-11-09 | $198.00K 10-Q · filed 2020-11-09 | $497.00K derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | $67.00K 10-Q · filed 2020-08-10 | $163.00K 10-Q · filed 2020-08-10 | $462.00K derived: sum of 3 quarters · filed 2020-08-10 | $756.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $96.00K 10-Q · filed 2020-05-11 | $395.00K derived: sum of 2 quarters · filed 2020-05-11 | $689.00K derived: sum of 3 quarters · filed 2020-05-11 | $957.00K derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $593.00K derived: sum of 2 quarters · filed 2020-03-16 | $861.00K derived: sum of 3 quarters · filed 2020-03-16 | $1.15M 10-K · filed 2020-03-16 | ||||||||||||
| 2018-09-30 | $294.00K 10-Q · filed 2019-11-12 | $562.00K derived: sum of 2 quarters · filed 2019-11-12 | $848.00K 10-Q · filed 2019-11-12 | $1.25M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||
| 2018-06-30 | $268.00K 10-Q · filed 2019-08-09 | $553.00K 10-Q · filed 2019-08-09 | $958.00K derived: sum of 3 quarters · filed 2019-08-09 | $1.21M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||
| 2018-03-31 | $285.00K 10-Q · filed 2019-05-10 | $690.00K derived: sum of 2 quarters · filed 2019-05-10 | $944.00K derived: sum of 3 quarters · filed 2019-05-10 | $1.25M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||
| 2017-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $659.00K derived: sum of 2 quarters · filed 2019-03-06 | $960.00K derived: sum of 3 quarters · filed 2019-03-06 | $1.23M 10-K · filed 2019-03-06 | ||||||||||||
| 2017-09-30 | $254.00K 10-Q · filed 2018-11-13 | $555.00K derived: sum of 2 quarters · filed 2018-11-13 | $827.00K 10-Q · filed 2018-11-13 | $1.10M derived: sum of 4 quarters · filed 2018-11-13 | ||||||||||||
| 2017-06-30 | $301.00K 10-Q · filed 2018-08-14 | $573.00K 10-Q · filed 2018-08-14 | $848.00K derived: sum of 3 quarters · filed 2018-08-14 | $911.00K derived: sum of 4 quarters · filed 2018-08-14 | ||||||||||||
| 2017-03-31 | $272.00K 10-Q · filed 2018-05-11 | $547.00K derived: sum of 2 quarters · filed 2018-05-11 | $610.00K derived: sum of 3 quarters · filed 2018-05-11 | $860.00K derived: sum of 4 quarters · filed 2018-05-11 | ||||||||||||
| 2016-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $338.00K derived: sum of 2 quarters · filed 2018-03-29 | $588.00K derived: sum of 3 quarters · filed 2018-03-29 | $741.00K 10-K · filed 2018-03-29 | ||||||||||||
| 2016-09-30 | $63.00K 10-Q · filed 2017-11-07 | $313.00K derived: sum of 2 quarters · filed 2017-11-07 | $466.00K 10-Q · filed 2017-11-07 | $705.00K derived: sum of 4 quarters · filed 2017-11-07 | ||||||||||||
| 2016-06-30 | $250.00K 10-Q · filed 2017-08-14 | $403.00K 10-Q · filed 2017-08-14 | $642.00K derived: sum of 3 quarters · filed 2017-08-14 | $850.00K derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||
| 2016-03-31 | $153.00K 10-Q · filed 2017-05-15 | $392.00K derived: sum of 2 quarters · filed 2017-05-15 | $600.00K derived: sum of 3 quarters · filed 2017-05-15 | $830.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||
| 2015-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-28 | $447.00K derived: sum of 2 quarters · filed 2017-03-28 | $677.00K derived: sum of 3 quarters · filed 2017-03-28 | $868.00K 10-K · filed 2017-03-28 | ||||||||||||
| 2015-09-30 | $208.00K 10-Q · filed 2016-11-08 | $438.00K derived: sum of 2 quarters · filed 2016-11-08 | $629.00K 10-Q · filed 2016-11-08 | $809.00K derived: sum of 4 quarters · filed 2016-11-08 | ||||||||||||
| 2015-06-30 | $230.00K 10-Q · filed 2016-08-09 | $421.00K 10-Q · filed 2016-08-09 | $601.00K derived: sum of 3 quarters · filed 2016-08-09 | $879.00K derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||
| 2015-03-31 | $191.00K 10-Q · filed 2016-05-10 | $371.00K derived: sum of 2 quarters · filed 2016-05-10 | $649.00K derived: sum of 3 quarters · filed 2016-05-10 | $894.00K derived: sum of 4 quarters · filed 2016-05-10 | ||||||||||||
| 2014-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $458.00K derived: sum of 2 quarters · filed 2016-03-15 | $703.00K derived: sum of 3 quarters · filed 2016-03-15 | $943.00K 10-K · filed 2016-03-15 | ||||||||||||
| 2014-09-30 | $278.00K 10-Q · filed 2015-11-09 | $523.00K derived: sum of 2 quarters · filed 2015-11-09 | $763.00K 10-Q · filed 2015-11-09 | $1.02M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-06-30 | $245.00K 10-Q · filed 2015-08-10 | $485.00K 10-Q · filed 2015-08-10 | $739.00K derived: sum of 3 quarters · filed 2016-03-15 | $862.00K derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||
| 2014-03-31 | $240.00K 10-Q · filed 2015-05-11 | $494.00K derived: sum of 2 quarters · filed 2016-03-15 | $617.00K derived: sum of 3 quarters · filed 2016-03-15 | $894.00K derived: sum of 4 quarters · filed 2016-03-15 | $5.34M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $254.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $377.00K derived: sum of 2 quarters · filed 2016-03-15 | $654.00K derived: sum of 3 quarters · filed 2016-03-15 | $867.00K 10-K · filed 2016-03-15 | $5.10M 10-K · filed 2014-03-21 | |||||||||||
| 2013-09-30 | $123.00K 10-Q · filed 2014-11-10 | $400.00K derived: sum of 2 quarters · filed 2014-11-10 | $613.00K 10-Q · filed 2014-11-10 | $887.00K derived: sum of 4 quarters · filed 2015-03-18 | $4.85M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $277.00K 10-Q · filed 2013-08-14 | $490.00K 10-Q · filed 2014-08-07 | $764.00K derived: sum of 3 quarters · filed 2015-03-18 | $1.00M derived: sum of 4 quarters · filed 2015-03-18 | $4.72M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $213.00K 10-Q · filed 2014-05-13 | $487.00K derived: sum of 2 quarters · filed 2015-03-18 | $725.00K derived: sum of 3 quarters · filed 2015-03-18 | $992.00K derived: sum of 4 quarters · filed 2015-03-18 | $4.45M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $512.00K derived: sum of 2 quarters · filed 2015-03-18 | $779.00K derived: sum of 3 quarters · filed 2015-03-18 | $976.00K 10-K · filed 2015-03-18 | $4.24M 10-K · filed 2013-03-29 | |||||||||||
| 2012-09-30 | $238.00K 10-Q · filed 2013-11-12 | $505.00K derived: sum of 2 quarters · filed 2013-11-12 | $702.00K 10-Q · filed 2013-11-12 | $995.00K derived: sum of 4 quarters · filed 2013-11-12 | $3.96M 10-Q · filed 2012-11-09 | |||||||||||
| 2012-06-30 | $267.00K 10-Q · filed 2013-08-14 | $464.00K 10-Q · filed 2013-08-14 | $757.00K derived: sum of 3 quarters · filed 2013-08-14 | $1.01M derived: sum of 4 quarters · filed 2013-08-14 | $3.72M 10-Q · filed 2012-08-10 | |||||||||||
| 2012-03-31 | $197.00K 10-Q · filed 2013-05-10 | $490.00K derived: sum of 2 quarters · filed 2013-05-10 | $743.00K derived: sum of 3 quarters · filed 2013-05-10 | $1.49M derived: sum of 4 quarters · filed 2013-05-10 | $3.46M 10-Q · filed 2012-05-11 | |||||||||||
| 2011-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $546.00K derived: sum of 2 quarters · filed 2013-03-29 | $1.30M derived: sum of 3 quarters · filed 2013-03-29 | $1.57M 10-K · filed 2013-03-29 | $3.26M 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | $253.00K 10-Q · filed 2012-11-09 | $1.00M derived: sum of 2 quarters · filed 2012-11-09 | $1.27M 10-Q · filed 2012-11-09 | $1.51M derived: sum of 4 quarters · filed 2012-11-09 | $2.97M 10-Q · filed 2011-11-10 | |||||||||||
| 2011-06-30 | $750.00K 10-Q · filed 2012-08-10 | $1.02M 10-Q · filed 2012-08-10 | $1.26M derived: sum of 3 quarters · filed 2012-08-10 | $1.50M derived: sum of 4 quarters · filed 2012-08-10 | $2.71M 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $272.00K 10-Q · filed 2012-05-11 | $510.00K derived: sum of 2 quarters · filed 2012-05-11 | $749.00K derived: sum of 3 quarters · filed 2012-05-11 | $976.00K derived: sum of 4 quarters · filed 2012-05-11 | ||||||||||||
| 2010-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $477.00K derived: sum of 2 quarters · filed 2012-03-30 | $704.00K derived: sum of 3 quarters · filed 2012-03-30 | $902.00K 10-K · filed 2012-03-30 | ||||||||||||
| 2010-09-30 | $239.00K 10-Q · filed 2011-11-10 | $466.00K derived: sum of 2 quarters · filed 2011-11-10 | $664.00K 10-Q · filed 2011-11-10 | |||||||||||||
| 2010-06-30 | $227.00K 10-Q · filed 2011-08-12 | $425.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |